Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas

J. Liu, L. Lahousse, M.G. Nivard, M. Bot, L.M. Chen, J.B. van Klinken, C.S. Thesing, M. Beekman, E.B. van den Akker, R.C. Slieker, E. Waterham, C.J.H. van der Kallen, I. de Boer, R.F. Li-Gao, D. Vojinovic, N. Amin, D. Radjabzadeh, R. Kraaij, L.J.M. Alferink, S.D. MuradA.G. Uitterlinden, G. Willemsen, R. Pool, Y. Milaneschi, D. van Heemst, H.E.D. Suchiman, F. Rutters, P.J.M. Elders, J.W.J. Beulens, A.A.W.A. van der Heijden, M.M.J. van Greevenbroek, I.C.W. Arts, G.L.J. Onderwater, A.M.J.M. van den Maagdenberg, D.O. Mook-Kanamori, T. Hankemeier, G.M. Terwindt, C.D.A. Stehouwer, J.M. Geleijnse, L.M. 't Hart, P.E. Slagboom, K.W. van Dijk, A. Zhernakova, J.Y. Fu, B.W.J.H. Penninx, D.I. Boomsma, A. Demirkan, B.H.C. Stricker, C.M. van Duijn

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)110-117
Number of pages20
JournalNature Medicine
Volume26
Issue number1
DOIs
Publication statusPublished - 1 Jan 2020

Keywords

  • circulating metabolites
  • design
  • diabetes-mellitus
  • magnetic-resonance metabolomics
  • mendelian randomization
  • obesity
  • population
  • profiles
  • risk
  • serum metabolome
  • POPULATION
  • PROFILES
  • DESIGN
  • SERUM METABOLOME
  • RISK
  • MENDELIAN RANDOMIZATION
  • CIRCULATING METABOLITES
  • DIABETES-MELLITUS
  • MAGNETIC-RESONANCE METABOLOMICS
  • OBESITY

Cite this